Tempus ECG-Low EF vs Viz RV/LV
AI Verdict
Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if you need to quickly screen patients 40 years or older for signs associated with low left ventricular ejection fraction (LVEF ≤40%) using a standard 12-lead ECG. This tool is ideal for identifying patients at risk of heart failure in a clinical diagnostic setting, prompting further evaluation without requiring advanced imaging initially.
View Tempus ECG-Low EF →Choose Viz RV/LV if…
Choose Viz RV/LV if you require automated, rapid assessment of right and left ventricular diameters from CTPA scans to stratify pulmonary embolism risk. This tool is best suited for emergency medicine and radiology workflows where timely identification of RV strain is crucial for managing suspected PE cases and coordinating care.
View Viz RV/LV →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-Low EF | Viz RV/LV |
|---|---|---|
| Deployment | Integrates with current ECG platforms and electronic health records (EHRs). | Cloud-based |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz RV/LVTool B (Viz RV/LV) offers a more comprehensive and interactive user experience, providing annotated images, AI-powered alerts, a high-fidelity mobile DICOM image viewer, and a HIPAA-compliant communication platform for care coordination. In contrast, Tool A (Tempus ECG-Low EF) operates primarily as a backend software, integrating into existing workflows without a dedicated user interface and providing a binary output within other medical systems.
Clinical Value
Viz RV/LVBoth tools are FDA-cleared and address significant clinical needs. However, Tool B (Viz RV/LV) focuses on rapid pulmonary embolism risk stratification and enhanced care coordination for a life-threatening acute condition, providing immediate and impactful clinical workflow improvements. Tool A (Tempus ECG-Low EF) aids in identifying patients at risk for heart failure, which is valuable for earlier intervention but less time-critical than PE.
Pricing & Value
TieNeither Tool A (Tempus ECG-Low EF) nor Tool B (Viz RV/LV) provides publicly available pricing information. Both require contacting the vendor for details, making it impossible to assess their cost-effectiveness or value proposition transparently.
Enterprise Readiness
Viz RV/LVBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs, indicating strong enterprise readiness. However, Tool B (Viz RV/LV)'s cloud-based deployment, integration into the broader 'Viz PE Solution,' and features for care coordination suggest a more scalable and comprehensive platform designed for multi-departmental enterprise use.
Innovation
Viz RV/LVWhile Tool A (Tempus ECG-Low EF) innovatively applies AI to extract new insights from standard ECGs, Tool B (Viz RV/LV)'s innovation extends beyond just diagnostic measurement. It combines AI analysis with real-time alerts, mobile viewing, and a communication platform for intelligent care coordination, representing a more holistic and advanced approach to leveraging AI in acute clinical workflows.
Support & Docs
TieThe provided structured facts and web search results do not offer specific details regarding customer support teams, user manuals, or comprehensive documentation for either Tempus ECG-Low EF or Viz RV/LV. Therefore, it is not possible to differentiate between the two on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-Low EF | Viz RV/LV |
|---|---|---|
| Tool Name | Tempus ECG-Low EF | Viz RV/LV |
| Company | Tempus AI | Viz.ai |
| Primary Function | Analyzes 12-lead ECGs to detect signs associated with low LVEF (u226440%) in patients 40+ at risk of heart failure. | Automates RV/LV diameter measurements from CTPA scans for rapid pulmonary embolism risk stratification. |
| Input Data Type | 12-lead ECG recordings (resting, non-ambulatory) | Volumetric CTPA acquisitions |
| Key Measurement/Output | Binary output (Low LVEF Detected / Not Detected) | Automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurement; annotated images |
| Target Condition | Low Left Ventricular Ejection Fraction (LVEF u226440%) / Heart failure risk | Pulmonary embolism risk stratification |
| Target Specialties | Cardiology, Emergency Medicine, Internal Medicine | Emergency Medicine, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and Viz RV/LV.
Frequently Asked Questions
More Comparisons
More matchups featuring Tempus ECG-Low EF or Viz RV/LV
Backers
Who funded each tool's parent company.